Skip to main content

Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India

Background

Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a major global health problem. It is the second leading cause of death worldwide. Drug resistance threatens global TB control with the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) TB. The burden of MDR TB and XDR TB in India is not available as continuous surveillance for drug resistance is not carried out. This study was done to determine the drug resistance patterns to first and second line drugs among new and previously treated patients with TB.

Methods

Sputum samples were collected from 100 suspected TB patients from a tertiary care referral hospital. After digestion and decontamination, samples were stained for microscopy and cultured in liquid (MGIT) and Löwenstein Jensen (LJ) medium to isolate M. tuberculosis. Drug susceptibility testing (DST) was done against first line (streptomycin, isoniazid, rifampin and ethambutol) and second line (kanamycin, capreomycin, ofloxacin and ethionamide) drugs.

Results

Among the 100 samples, 56 were smear positives and M. tuberculosis was isolated from 61 samples cultured in MGIT and 46 in L J medium. Of which 20 (32.7%) were MDR strains. Among the MDR strains, 9 (45%) were XDR strains. Two strains were totally resistant to all the 8 drugs. The proportion of MDR and XDR was highest among the previously treated patient.

Conclusion

This study underscores the need for DST in all TB patients particularly in the previously treated patients. New drugs, novel treatment strategies and adherence to treatment are needed to effectively treat and control drug resistant TB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Kenneth.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Udaykumar, A.J., R, J., Mishra, B. et al. Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India. BMC Infect Dis 14 (Suppl 3), O3 (2014). https://doi.org/10.1186/1471-2334-14-S3-O3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1471-2334-14-S3-O3

Keywords

  • Tuberculosis
  • Ofloxacin
  • Ethambutol
  • Drug Susceptibility Testing
  • Ethionamide